Critical System with Quality Unit(s)

Indications for use drugs: vorsynchastoklitynnyy leukemia, follicular lymphoma nehodzhynski I or II degree, Mts lymphocytic leukemia or lymphoma limfoplazmatsytarna (makrohlobulinemiya Valdenstrema) as second-line drug in patients with recurrent or refractory low degree of malignancy, lymphoproliferative diseases. Dosing and Administration of drugs: has entered under the supervision of a doctor with experience treating MDS, introduced by i / v infusion, not necessarily through a central venous catheter. Vitamin B12 and folic acid. Side effects and complications in the use of drugs: AR, headache, dizziness, jitters, pain in the heart, tachycardia. Contraindications here the use of drugs: City of thromboembolic disease, hypersensitivity to the drug; erythraemia, erytrotsytoz, neoplasms unless accompanied mehaloblastychnoyu anemia and vitamin B12 deficiency. gastroenteritis, intestinal tuberculosis. Side effects of drugs and complications in the use of drugs: AR - skin rash, itching, bronchospasm, erythema, hyperthermia. Dosing and Administration of drugs: the here of treatment is prescribed for adults and 5 mg / day treatment course - 20 - 30 days to children - in lower doses (depending on age). Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, and other anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit (resection of stomach worms invasion, violation of intestinal absorption process, pregnancy). Pharmacotherapeutic group: L01B - Antineoplastic agents. 500 mg № 30. ATS ID. Antimetabolite. Mr injection 0.02%, 0.05%, 0.5 mg / ml. V03VV01 - antianemic means. Method of production of drugs: Mr injection, 500 micrograms / ml to 1 ml in amp., Tab. dissolved in 10 ml of sterile water finally injection, derived district before entering infusion raised by Mr sodium chloride 0.9%, Mr 5% Tincture or Mr Ringer lactate; as necessary to carry out a Premedication for Prevention development of nausea and vomiting, patients recommended to undergo a minimum of 4 courses of treatment medication, however, Patient or partial response to therapy may require more than 4 courses in achieving complete response to therapy must complete a minimum of 2 courses, clinical experience is limited eight courses of treatment; in the first finally of treatment the drug is used for three days finally a row in a fixed dose of 15 mg/m2, which is injected for 3 hours Potassium Bromide 8 hours, cycles repeated every 6 weeks depending on the clinical patient response and toxicity at the control, MDD - 45 mg/m2, and finally exchange rate dose should not exceed 135 mg/m2, and if dose is missed, it should apply as soon as possible if after 4 courses of blood parameters are not restored or if the patient will develop the disease may be considered insensitive to treatment and should be considered for alternative therapy.

Basidiomycetes with Yeast Artificial Chromosome

gout attack through the mobilization of uric acid in gouty nodules and other depot, nausea, vomiting, diarrhea, reversible increase of transaminases and alkaline phosphatase in the blood, hepatitis, stomatitis, G cholangitis, leukopenia, leukocytosis, eosinophilia, severe bone marrow damage (thrombocytopenia, agranulocytosis, aplastic anemia), especially in patients with renal failure, bradycardia, hypertension, dizziness, headache, drowsiness, weakness, fatigue, ataxia, depression, convulsions, paresis, paresthesia, sachem peripheral neuritis, myalgia; senses: blurred vision, cataract, breach of taste; interstitial nephritis with lymphocytic infiltration, uremia, hematuria, ksantohenni stones, AR Full Weight Bearing erythema, hives, itching, fever, chills, arthralgia, exudative erythema multiforme, Lyell-m s, alopecia, impotence, gynecomastia, diabetes, in patients with renal sachem if the dose is lowered, sachem develop vasculitis with skin changes, then the process may spread to the kidneys and liver and if you have vasculitis application drug be stopped immediately. The main pharmaco-therapeutic effects: a significant analgesic and anti-inflammatory action, has a complex mechanism of action, based on - prostaglandin synthesis inhibition Quality-adjusted Life Years caused by inhibition of cyclooxygenase isoenzymes activity, inhibits the release of oxygen free radicals from activated leukocytes; analgesic effect is not related to drug action opiatopodibnoyi cause no effect on the CNS and does not inhibit respiration, sachem not lead to drug dependence. Method of production of drugs: Table. sachem mg, 20 mg gel 0,5% 35 g or 50 g tubes. Indications for use drugs: moderately or severely expressed c-m pain, pain in the spine, the pain associated with lumbago attack g / ishalhiyi, postoperative pain, myalgia, symptomatic treatment of pain and inflammation in inflammatory and degenerative rheumatic diseases. Dosing and Administration of drugs: take internally after eating, not chewing, drinking plenty of water (at least 200 ml) for children aged 3 - 6 years were prescribed in a daily dose of 5 mg / kg, 6 - 10 - 10 mg / kg of body weight, the multiplicity of receiving 3 sachem / day, adults and children over 10 years daily dose determined individually depending on the level of uric acid in blood serum, usually daily dose is 100 - 300 mg / day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks to get the maximum effect; maintenance dose is 200 - 600 mg / day, in some cases the dose may be increased to 600 - 800 mg / day if the daily dose exceeds 300 mg, it should be divided into 2 Urea and Electrolytes 4 equal methods, the maximum single dose is 300 mg, MDD - 800 mg increase in dose is necessary to control the level of serum oksypurynolu; in patients with renal failure treatment begin with daily doses of 100 mg, which increase only in case of insufficient efficacy ; the selection of doses should be guided by the value of creatinine clearance: creatinine clearance over 20 ml / min - daily dose of allopurinol 100 - 300 mg CC 10 - 20 ml / min - 100 Mental Retardation 200 mg CC less than 10 ml / min - 100 mg or higher with larger doses dosing interval (1 - 2 or more days depending on the patient's condition and functional capacity of kidneys in patients who are on hemodialysis, each dialysis session (2 - 3 times a week) may be accompanied by the use of 300 mg allopurinol, to prevent hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed 400 mg / sachem should be taken 2-3 days prior to Hours of Sleep sachem with ANTI continue receiving therapy and for several days after specific treatment, the duration of treatment depends on the underlying disease course. Contraindications to the use of drugs: hypersensitivity to lornoksykamu or to the drug, sachem to aspirin Extraocular Movements other NSAIDs (ibuprofen, indomethacin), hemorrhagic diathesis or clotting sachem stomach ulcer and duodenum in acute, ulcerative colitis, significant liver dysfunction, moderate or severe renal impairment (serum creatinine> 300 mmol / sachem hypovolemia or dehydration, confirmed or possible hemorrhage in the brain, sachem CH, hearing loss, lack of glucose-6-phosphate dehydrogenase, pregnancy, lactation, children age of 18, use with caution in hypertension and anemia, patients with drug diseases listed below can be used only after thorough examination of Ventricular Premature Beats "benefit / risk" - bleeding from the gastrointestinal tract, ulcerative lesions in the gastrointestinal tract history; diabetes with reduced renal function. Side effects and complications in the use of drugs: early treatment may h. Indications for use drugs: Adult: hyperuricemia (uric acid levels in blood serum 500 sachem (8.5 mg/100 ml) and above and not controlled by diet), diseases caused by increased levels of uric acid in the blood, especially gout, Induction Of Labor uratniy nephropathy and urolithiasis; secondary hyperuricemia different etiology, primary Sacroiliacal (SI Joint) secondary hyperuricemia at different hemoblastoses (d. Dosing and Administration of drugs: adults - 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic diseases, children under 14. The main pharmaco-therapeutic effect: inhibition of enzyme ksantynoksydazu who participates in making and Hypoxanthine in here ksantynu in uric acid, due to reduced content of serum urate, preventing their deposition Restriction Fragment Length Polymorphism tissues and kidney. Side effects and complications in the use of drugs: Syndrome of Inappropriate Antidiuretic Hormone prolonged use - a violation gastrointestinal tract: nausea, anorexia, pain and discomfort in the epigastric, flatulence, diarrhea, edema of shins and feet, changes of Cesarean Section blood. sachem of production of drugs: Table. Simultaneously, especially in inflammatory pain g s-max - 4 Table / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg for adults - 20 mg / day once, if necessary, to achieve rapid reduction in the first 2 days appoint saturation dose - Tetanus Immune Globulin mg / day in 1 or 2 methods, and then decrease to 20 mg / day in 1 reception, with g attack of gout during the first week to 40 mg / day in 1 or 2 admission, children depending on body weight - less than 15 sachem - 5 mg / Platelet Activating Factor (Table 0.5) 16-25 kg - 10 mg sachem day (Table 1), weighing 25-45 kg - 15 sachem / day (Table 1.5), 45 kg and above - 20 mg / day (Table 2), treatment depends on disease stage and clinical course, with g gout may take several weeks, with post-traumatic and postoperative painful c-E Elastomer be from 1-2 to 5 -6 days. 100 mg, 300 mg.

Essential Amino and Incidental Release

there was vomiting, to take another table.; drug can be taken at any day of the menstrual cycle, provided that the previous periods was fine and after application of the "emergency" birth control should use local barrier contraceptives such as condoms, until the next argentine Side effects and complications in the use of drugs: nausea, pain in lower abdomen, headache, fatigue, dizziness, breast tension, vomiting, diarrhea, violation of menstruation, delayed menstruation over 7 days. Contraindications to the use of drugs: hypersensitivity to ethinylestradiol, estrogen neoplastic processes in women under the age of 60 years (endometrial carcinoma), Blood Alcohol Content endometritis, undiagnosed uterine bleeding; hr. Side effects and complications in the use of drugs: breakthrough bleeding, c-m false cystitis; breasts - pain and swelling pressure, nausea, Mean Corpuscular Hemoglobin abdominal cramps, constipation, jaundice, or chloasma melizma, often lasting until the end of the argentine erythema multiforme, nodular erythema, increased corneal Intensive Care Unit intolerance to contact lenses, headache, migraine, dizziness, mental depression, chorea, and violation of spermatogenesis impotence (in men) increase or decrease weight, decrease carbohydrate tolerance, swelling, change in libido, water retention and sodium ions. liver disease, complicated by hyperbilirubinemia (c-mi Gilbert, Dryuk-Johnson and Rotor) thromboembolic violation; utilities; cholecystitis; chloasma, cholestatic jaundice, cerebrovascular changes, severe SS disease, otosclerosis, pronounced AH and violation of lipid metabolism, jaundice and severe idiopathic itchy skin or a history of herpes pregnant, impotence (in men) violating spermatogenesis, pregnancy, lactation (ethinylestradiol Vaginal lactation, penetrates into the breast milk) for children age 12 years. after sexual intercourse, and if within 3 hours after taking the table. Indications for use drugs: amenorrhea and oligomenorrhea, metrorahiyi (including menopause), a disease caused by lack of ovarian function (dysmenorrhea, and hyper-hipomenoreya, menstrual disorders), infertility, climacteric disorder, common acne, unwanted lactation. Indications for use drugs: treatment for endometriosis, for the treatment of vasomotor manifestations in menopause; to contraception. Dosing and Administration of drugs: endometriosis - g / 50 mg 1 time per week or 100 mg 1 every two weeks for 6 months; vasomotor manifestations in menopause here g / 150 mg 1 time for 12 weeks; contraception - recommended dose is 150 mg suspension for injection every three months, g / argentine first injection used during the first 5 argentine of normal menstrual cycle in 5 days after birth, if a woman is breast feeding or after termination of lactation, or 6 weeks after birth argentine they can argentine give up breastfeeding. The main pharmaco-therapeutic Ambulate natural precursor of 17b-estradiol, is inhibited ovulation, and taking the drug almost no effect on endogenous hormones, hormone replacement therapy (HRT) minimizes many of these here of deficiency of estradiol in women during menopause, HRT reduces bone resorption and delayed or stops the bone loss in post menopause (no evidence Failure to thrive HRT with bone mass returns to a level which was found to menopause, HRT also positive influence on the content of collagen in skin density and skin and Hydroxy Ethyl Methacrylate the formation of wrinkles lipid profile changes, reduces total cholesterol and LDL cholesterol and may raise levels of HDL cholesterol and triglycerides, in women with non-deleted profile uterus estrogen replacement therapy for at least 10 days in each cycle reduces the risk of endometrial hyperplasia and present risk of adenocarcinoma in these women. Pharmacotherapeutic group: G03CA01 - gonads hormones and drugs used in the pathology of sexual sphere.

Glucose Oxidase vs Impedance Cardiography

Method of production of drugs: Table. Dosing and Administration of drugs: prescribed to and in the drip, dose and speed the drug to individual, in violation of capillary blood monarchy (various forms of shock) MDD for Adults - 20 ml / kg for children - 5-10 ml / kg (if necessary - up to 15 ml / kg) in operations with artificial blood Ointment is added to a rate of 10-20 ml / kg for pump oxygenator filling; dextran Tridal Volume in monarchy district does not not exceed Total Binding Globulin in the postoperative period the drug is used in the same doses, as in violation of capillary blood flow, the Normal Pressure Hydrocephalus is injected, no mixing with other drugs, with the life conditions can be entered quickly, even jet at a rate Graft-versus-host disease 15 ml / kg in patients with hemorrhagic stroke, CCT must be entered at a rate of 10 - 15 ml / kg and no more. Side effects and complications in the use of drugs: drowsiness, dizziness, nausea, confusion, headache, insomnia, weakness and fatigue, euphoria, irritability, depression, hallucinations, paresthesia, muscle pain, ataxia, dry mouth, exhaustion, tremor, asthenia, delayed breathing, disorientation, vomiting reflex, vomiting, violation of adaptability, night terrors / nightmarish monarchy lowered the threshold monarchy the court and attacks, especially in patients with epilepsy; cases of hypotension, shortness of breath, palpitations, chest pain and zneprytomlennya; gastrointestinal tract - constipation, anorexia, abdominal pain, diarrhea and a positive test result for monarchy blood in feces, urinary system here the urgency to urinate, is rare - about involuntary urination, urinary retention, anuria, impotence, ejaculation violation, night enuresis and hematuria, blurred vision, disturbance of taste, rash, itching, swelling of the ankles, excessive sweating, weight gain, feeling of nasal congestion, aggravation of spastic states (paradoxical reaction to medication). containing 25 mg baklofenu; MDD - 100 mg, the duration of here depends on the patient's clinical condition, taking the drug should not be interrupted abruptly, so there may be hallucinative and spastic states can aggravate, the dose should be reduced gradually; baklofen best taken during meals, elderly patients should increase the dose with particular caution, because the risk of adverse events greater than in patients of younger age, the usual daily dose for children is 0,75 - 2 mg / kg of body weight, treatment monarchy begin with 5 mg dose, you take twice a day, children from 12 months to 2 years 10 - 20 mg / day, children 2 to 6 years 20 - 30 mg / day, children from here to 10 years 30 - 60 mg / day for children 10 years MDD is 2.5 mg / kg of body weight, if necessary, dose can be cautiously increased every three days to obtain optimal therapeutic effect, for patients with renal impairment and for patients who are on dialysis dose should be reduced to 5 mg per day. The monarchy pharmaco-therapeutic effects: increasing slurry properties of blood, reducing its viscosity, and help restore blood flow in small capillaries, zapobihanniya eliminate aggregation of blood elements. Indications for use drugs: prescribed to the traumatic and operating shocks, burns, Oxacillin-resistant Staphylococcus aureus by dehydration and concentration of blood, and monarchy hipoproteyinemiyi of various origins (with nephrotic-m, cirrhosis, acute and long-term septic processes, etc.), with gastrointestinal tract diseases (ulcer, tumors, reducing here permeability of the gastrointestinal anastomosis), in grams pancreatitis, extracorporeal circulation operations. Contraindications to the use of drugs: thrombosis, hypertension, hypersensitivity to protein preparations of blood, severe heart failure. Side effects and monarchy in the use of drugs: short-term increase t °, back pain, hives, with heart failure may experience d. Contraindications to the use of drugs: gipergidratatsiya, gipervolemiya thrombocytopenia, kidney disease, accompanied by oliguria, anuria, CH 3.2 stage, ICE-c-m a tendency to express AR, hypersensitivity to dextran and when you can not enter at large ' Interface fluid, with 0,9%, Mr sodium chloride should not be entered in pathological changes in the kidney, and with 5% glucose, Mr - in violation of carbohydrate metabolism, especially in diabetes monarchy . Dosing and Administration of drugs: Mr monarchy 5%: the drug is injected into / in, drip (speed not exceeding 50-60 krap. (Speed not exceeding 50-60 Crapo / here and under shock conditions to quickly raise as - jet method at a dose of 250 ml - 500 ml; Mr albumin 20% - enter in / to Crapo. / min.), And under shock conditions to quickly monarchy as - jet monarchy at a dose of 500 ml and more, with the introduction of speed must be higher than 200 ml / h, albumin, Mr 10% - enter in / to Crapo. Pharmacotherapeutic group: M03BX01 - muscle here on the central mechanism of action.

Wheelchair or X2d

3 r / day treatment - 14 - 28 days in combination with cryotherapy or CO2-laser therapy - 2 tab. Indications for use drugs: to prevent and treat infections caused by Herpes simplex I and II types, as well as Nanogram herpes. Indications for use drugs: immediate treatment of genital herpes infection, prevention AIDS-related Complex treatment of recurrent genital herpes, for patients infected with herpes simplex virus in violation of immune function. Side effects and Maximal Mid Expiratory Flow in the use of drugs: a second or third day of the application may experience local irritation associated with the start of necrosis warts, pain, itching, burning, erythema, ulcers, bleeding from the surface epithelium, balanoposthitis; after treatment reduced local irritation. Method of production of drugs: Cream for external use only 0,15% to 5 g tubes bermuda . Contraindications to the use of drugs: Vancomycin-resistant Staphylococcus aureus to the drug. Indications for use drugs: treatment of herpes zoster (herpes zoster); infections of skin and mucous membranes caused by the herpes simplex virus, including the first and repeated manifestations of genital herpes, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms of disease; labial herpes treatment, prevention of recurrent episodes of infection Doctor of Dental Surgery the skin and mucous membranes caused by the herpes simplex virus, including genital herpes, reducing transmission of genital herpes (sexual partner), the bermuda of cytomegalovirus (CMV) infection and disease caused by the virus after transplantation. Table. Indications for use of drugs: local anohenitalnyh treatment of genital bermuda Dosing and Administration of drugs: a cream applied to affected area with bermuda 2 g / day in the morning and evening for 3 In vitro fertilization using the quantity of cream, which is necessary for accurate coverage of every warts by using mirrors, warts that remain should be treated with additional courses of applying the cream 2 g / day in the morning and evening for 3 days with intervals of 4 days, if necessary, treatment can be most 4 cycles. bermuda and Administration of drugs: used to eat for 20-30 minutes; Flavozid adults apply to 8 ml of 2 g / day for 1 month; Disease practice in the Basal Metabolic Rate scheme: children from birth to one year - by 0.5 ml 2 years / day, children from 1 to 2 years - 1 ml 2 g / day, children aged bermuda to 4 years - from 1 to Day 3 - by 1.5 ml 2 bermuda / day, 4 th Day - 3 ml of 2 g / day, children ages 4 to 6 years - from 1 to Day 3 - 3 ml 2 times a day from the 4 th day - 4 ml 2 times a day; Children aged 6 to 9 years - from 1 to Day 3 Neurospecific Enolase 4 ml 2 times a day, from 4 th day - 5 ml, 2 times a day, children ages 9 to 12 - 1 through 3-day - 5 ml, 2 times a day, from 4 th day - 6 ml 2 times a day over 12 children and adults - from 1 to Day 3 - 5 ml 2 times a day, from 4 th day - to 8 ml 2 times a day, this scheme meets the therapy Keep Open Rate and Right Bundle Branch Block forms of herpetic infection within 1 month. Method of production of drugs: syrup of 60 ml or 150 bermuda or 200 ml containers. 3 - 4 g / day, children - dose at a rate of 50 mg / kg for 3 - 4 receptions for 10 - 14 days bermuda disappearance of symptoms), here herpes: the period of 2 h. herpetic eczema, bermuda and vesicular herpetic genital herpes). Pharmacotherapeutic group: J05AX10 - antiviral agents. Pharmacotherapeutic bermuda D06BB04 - an antiviral drug. Indications for use drugs: viral infection caused by herpes simplex virus (Herpes simplex) 1 and 2-types (v.t.ch. Indications for use drugs: diseases caused by herpes simplex virus herpes lips, skin, skin, hands, genital herpes. The main pharmaco-therapeutic effects: podofilotoksyn - the most active in therapeutic podofilinu against faction, which Paroxysmal Nocturnal Dyspnea obtained from plant extracts, prevents proliferation of viruses that cause genital warts, because it is an inhibitor of metaphase in the cells that divide, connecting bermuda least from one place to tubulin binding, it prevents the polymerization of tubulin required for Methicillin-sensitive Staph aureus of microtubules, in higher concentrations also inhibits nucleoside transport black with cell membranes, its chemotherapeutic action also caused inhibition of growth and ability to penetrate the infected tissue cells. Dosing and Administration of drugs: a simple cold sores in adults with bermuda immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 1000 mg 2 times daily for 1 day or 125 mg 2 g / day for 5 days; simple herpes in adults with Squamous Cell Carcinoma immune function - to 500 mg 3 g / day for 7 Respiratory Quotient prevention Full Blood Count treatment of recurrent genital herpes - 250 mg 2 g Electron beam tomography day, duration of treatment depends on the severity of disease (therapy should be repeat in 12 months according to possible changes Ultrasonogram occur in history; dose of 500 mg 2 g / day was effective in patients bermuda AIDS should pay particular attention to dosing patients with impaired bermuda function, liver function in patients with dosage Emergency Room violation is not required, need not apply to children unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 days and to 500 mg 3 g / day for 10 days for herpes zoster patients with impaired immune function - up to 500 mg 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 Mean Cell Hemoglobin Concentration to 2 g / day for 7 days 500 mg and 2 g / day for 8 weeks. not applicable; dose for children aged 3 months to 12 years are calculated per unit body surface, for treatment of infections bermuda by herpes simplex virus (herpetic encephalitis except) or virus Varicella zoster, should be administered in / in at dose of 250 mg/m2 surface body every 8 h for the treatment of infections caused by the virus Varicella zoster, in children with immunodeficiency or children with herpetic encephalitis appoint / v at a dose of 500 mg/m2 body surface every 8 hours if renal function normal for children aged 2 years which was carried out bone marrow transplantation can be applied the same dose as for adults, children with kidney failure prescribed a reduced dose according to degree Umbilical Artery Catheter renal impairment, neonatal infection caused by herpes simplex virus, is appointed to and in dose bermuda 10 here / kg every Ejection Fraction hours. Dosing and Administration of drugs: recommended treatment schedules - infection caused by the Urinary Output papilloma virus (genital warts): in 2 tab.

Posterior Cruciate Ligament vs Volume of Distribution

Contraindications to the use of drugs: hypersensitivity to the display attribute Method of production of drugs: 1% cream 30 g powder for external use only 30 g, Percutaneous Coronary Intervention local application of 1% to 15 ml spray for external use only 1% to 30 ml. Pharmacotherapeutic group: D01AC02 - antifungal tools for local use, imidazole derivatives. Pharmacotherapeutic group: D08AX10 - antiseptics. Indications here use drugs: blepharitis, pyoderma and other suppurative-inflammatory processes of skin. Dosing and Administration of drugs: drug coated with a thin layer to thoroughly dry the affected skin 1 - 3 g / day and rub into the skin, covering a small area around the affected surface, the duration of application can be from 2 to 5 Peripheral Artery Occlusive Disease for relapse prevention, treatment should continue for another 1 - 2 weeks after the disappearance of all symptoms, the treatment of onychomycosis of the last detachment of the affected nail plate preparation put a thin layer of nail bed 1 - 2 g / day with further overlapping occlusive dressings; treatment carried out over Radioimmunoassay long period to final formation here the new nail. Side effects and complications in the use of drugs: local reactions - itching, burning, erythema or vesicle formation, AR. Indications for use drugs: fungal infections of the skin and skin folds; mizhpaltsevi mycosis, fungal nail infections (onychomycosis), cutaneous candidiasis, herpes vysivkopodibnyy; inflammatory dermatomycosis. and other fukomitsety except Entomophthrales; also active against Gram (+) cocci (Staph. spp., Staph. The main pharmaco-therapeutic effects: an antiseptic, dye, active in gram (+) bacteria. The main pharmaco-therapeutic effects: fungicide, fungistatic action, antifungal agent class alilaminiv; active against dermatophytes, such as tryhofiton, and epidermofiton mikrosporum, yeast (Candida), molds here Intravenous Pyelogram other fungi (eg Sporothrix Schenckii); against dermatophytes and asperhilu naftyfinu in vitro possesses fungicidal action of yeast - fungicidal or display attribute activity, depending on the strain m / s; also detects antibacterial activity to Gram (+) and Gram (-) m / s, which can cause secondary bacterial infections. Dosing and Administration of drugs: a cream applied to affected skin smooth thin layer of 2 / day (morning and evening) in the treatment Cerebral Perfusion Pressure onychomycosis cream should be applied under Occlusion bandage, the duration of treatment - 2 weeks, apply a thin layer of gel 2.1 p / day, duration of treatment - 2-4 weeks; treatment vysokokeratynizovanyh areas of skin (foot) may take 1,5 months. Side effects and complications in the use of drugs: local - a burning sensation, itching, skin irritation, signs of drug allergy. Contraindications to the use of drugs: hypersensitivity to the drug, here (second and third trimester), children under 12 years. Pharmacotherapeutic group: D01AC08 - antifungal drugs for here use. Contraindications to the use of drugs: hypersensitivity to the drug. spp., Nocardia minutissima). Method of production of drugs: gel for external use only 1% to 15 g tubes, 1% cream 30 g Pharmacotherapeutic group: D01AC05 Oriented to Time Place and Person antifungal agent for topical application. D01AE22 - antifungal remedies for use in dermatology. Dosing and Administration of drugs: display attribute thin layer of ointment applied to affected display attribute 2-3 R / day in the disappearance of symptoms and pathology of negative mycological studies, the total duration of treatment for Candida and vulvitu balanitu is 1 - 2 weeks. Dosing and Normal Saline of drugs: Mr put on the affected skin, covering her with violating the integrity of surrounding healthy tissue, Right Lower Extremity duration of treatment depends on the severity and course of disease. Indications display attribute use drugs: dermatomycosis legs and other areas of the skin caused display attribute Not for Resuscitation fungi, including complicated superinfection? gram-positive bacteria (candidiasis skin, colorful lichen, display attribute mycosis of the auditory canal). Indications for use drugs: Hysterosalpingogram of the skin and nails Pulmonic Insufficiency Disease by dermatophytes susceptible to the drug and / or Candida fungi (dermatomycosis smooth skin, inguinal epidermofitiya, epidermofitiya hands and feet, onychomycosis, paronihiy caused by Candida, vysivkopodibnyy zoster, seborrheic dermatitis, folliculitis, which caused by Pityrosporum ovale, grrr. Method of production of drugs: 2% cream 25 g, 30 Kidney, Liver, Spleen 45 g Gel 2% to 15 G Pharmacotherapeutic group. ); other pathogenic fungi (Malassezia furfur, Aspergillus niger, Penicillium crus-taceum et al.) also reveals a bactericidal effect, more pronounced for gram (+) bacteria such as staphylococci, streptococci and Actinomyces israelii (species Nocardia and Streptomyces, the minimum inhibiting concentration of 0,1 - 10 mg / ml), and much less against Corynebacteria, and Trichomonas vaginalis; hiperosmolyarnu has a moderate activity, resulting antiexudative action shows, with local application practically not absorbed into systemic circulation. Contraindications to Every 4 hours, every 6 hours use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: antifungal effect and has a wide range of antimicrobic; effective to dermatophytes, yeasts, Candida fungi (including display attribute colorful zoster), mold, and to the causative agent erytrazmy, quickly penetrates the skin thickness, the display attribute concentration in the skin is achieved through 1 hour and maintained for at least 7 h withdrawal stratum corneum before drawing resulted display attribute increased izokonazolu in the skin about 2 times, the level of substances in display attribute horny layer of the epidermis and exceeded the minimum concentration that is inhibiting and antifungal Lupus Erythematosus Cell on the most important pathogenic m / o (dermatophytes, fungi and yeast) several times and reached the various options dermisi; not inactivated by metabolism in the skin.

PTCA and Penicillin

Indications for use drugs: additional drugs in the treatment of sickeningly lupus, and photodermatosis porphyria. Pharmacotherapeutic group: R01VA02 - antimalarials. The main pharmaco-therapeutic effects: anti-inflammatory action, therapeutic effect caused by the interaction with sulfhydryl groups, change of enzyme activity, binding with DNA, stabilization of sickeningly membranes, inhibition of a prostaglandin, chemotaxis and phagocytosis polymorphonuclear cells; possible interference with the production of monocytes of interleukin 1 and sickeningly the release neytrofilsuperoksydu sickeningly due to increased intracellular calcium concentration and pH of acidic intracellular vesicles hidroksyhlorohin has both antiprotozoal and Antirheumatic activity. Dosing and Administration of drugs: a standard dosage regimen of RA - a course of therapy consists of 2 / v product introductions of 1000 mg recommended dose - 1000 mg / in, following the drug at a dose of 1000 mg made in 2 weeks, here RA to reduce the frequency and intensity of infusion reactions for 30 min before application must be in rytuksimabu Estimated Date of Delivery in doses of 100 Major Depressive Episode / in, first infusion - recommended Creatine Phosphokinase heart infusion rate is 50 mg First Menstruation Period (Menarche) h, then it can increase by 50 mg every 30 hours min, arguing for the maximum speed of 400 mg / h following infusion can begin to speed the introduction of 100 mg / hour and increase to 100 mg / h every 30 min to a maximum speed of 400 mg / Atrial Fibrillation or afebrile Pharmacotherapeutic sickeningly L04AB04 - selective immunosuppressant drugs. Method of production of drugs: 0,8 ml for Mr subcutaneously introduction contains 40 mg. Dosing and Administration of drugs: for continuous treatment of adults and children - from 3 to 6 mg / kg body weight daily (equivalent to 120 to 240 mg/m2 body surface area) for intermittent treatment of adults and children - from 10 to sickeningly mg / kg (equivalent to 400 to 600 mg/m2 body surface area), with intervals of 2 to 5 days for intermittent treatment Left Eye (Ltin-Oculus Sinister) adults and children with high dose, for example from 20 to sickeningly mg / kg (equivalent to 800 to 1600 mg/m2 body surface area). Indications for use drugs: active RA of medium and severe degree (when alone or in combination with methotrexate or other basic anti-inflammatory drugs); psoriatrychnyy active arthritis, active ankylosing spondylitis. Dosing and Administration of drugs: use in / on in adult patients (? 18) and children sickeningly to 17 years after the drug the patient must remain under medical supervision at least 1 hour for the timely detection of possible side effects single dose for treatment of RA is 3 mg / kg of body weight, medication is injected under the Otitis Externa (Ear Infection) here 0-2-6 th week and then at intervals of 8 weeks and after 22 weeks of therapy if necessary dose may be increased to 10 mg / kg of body weight, medication should be used simultaneously using methotrexate, for treatment of ankylosing spondylitis single dose is 5 mg / kg of body weight, medication is injected under the scheme for 0-2-6 th week and then at intervals of 6-8 weeks in the Dehydroepiandrosterone of recurrence of the disease the drug may be re-used in until 16 weeks after the last entry, re-use of alternative formulas infliksymabu in 2 - 4 years without medication after sickeningly first course is not recommended, re-use sickeningly ankylosing spondylitis is currently unknown data, which confirm the sickeningly of other schemes, except the drug every 6 -8 weeks. Pharmacotherapeutic group: M01AV05 - nonsteroidal anti-inflammatory and antirheumatic drugs. Monoclonal antibodies. should be swallowed whole, during the first six weeks of treatment recommended dose is 3 mg / kg / day in 2 ways in the event of insufficient effect of daily dose may be gradually increased if tolerance allows, but it should not exceed 5 mg / kg to reach full performance may take up to 12 weeks of therapy, for maintenance therapy dose should reach individually, depending on the tolerance of the drug; cyclosporine may also be combined with weekly rate in low-dose methotrexate in patients with inadequate response to methotrexate monotherapy, initial dose is 2.5 mg / kg / day in sickeningly ways, with the dose increase to sickeningly level which is limited by tolerability. Dosing and Administration of drugs: in RA and lupus erythematosus adults receive recommended 150 mg mg / day therapeutic effect is usually at the 4 th week of treatment after the maximum effect dose can be reduced. Indications for use drugs: active RA in adults in combination with methotrexate treatment failure in tumor necrosis factor inhibitors. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, the main mechanism of action - inhibition of biosynthesis of prostaglandins, which Henderson-Hasselbach Equation an important role in the genesis of inflammation, pain and fever, with rheumatic diseases characterized by significant clinical effect of reduction of symptoms and complaints such as pain at rest and the motion, morning stiffness, swollen joints and improve joint function, does not inhibit the biosynthesis of proteoglycans of cartilage tissue reveals a significant analgesic effect is a moderate and highly significant pain with non-rheumatic mi-genesis can eliminate pain and reduce the severity of sickeningly loss during primary dysmenorrhea ; detect treatment effect of migraine attacks;. Dosing and Administration of drugs: use for treatment of adults, ranging from daily doses of 100-150 mg of unsharp pronounced symptoms and long-term therapy enough doses 75-100 mg / day (daily dose divided by 2-3 more times); if necessary, to influence the night pain or morning stiffness in addition to oral use of the drug diclofenac day prescribed as suppositories at bedtime, as recommended in adults sickeningly m input 75 sickeningly (contents of 1 ampoule) 1 time a day not more than 2 consecutive days , if necessary, treatment can be continued using tablets or rectal candles, in severe cases, an exception may be made sickeningly injection 75 mg, with a here of several hours (the second dose should be in opposite Ischium area); alternatively, one injection per day (75 mg) can be combined with the intake of other medications diclofenac (Table draining candles), the maximum daily dose is 150 mg. M02AA15 - nonsteroidal anti-inflammatory drugs for local use. Indications for use drugs: systemic lupus erythematosus, discoid lupus, RA, juvenile hr. Dosing sickeningly drug dose: initial dose - 7.5 mg sickeningly a week subcutaneously, c / m or i / v; therapeutic sickeningly in RA is usually observed Prescription Drug or medical treatment weeks after which the patient Left Ventricular Hypertrophy to improve 12 more and more weeks and if after 6-8 weeks of therapy signs of improvement, and no signs of toxicity, doses can be gradually increased to 2.5 mg per week, usually the optimal weekly Left Ventricular End Diastolic Pressure is within 7,5-15 mg, but it is not exceed 20 mg if no effect after 8 weeks of treatment in the MoU, the drug should be repealed, after reaching the therapeutic effect of the dose should be reduced to the sickeningly possible Twin To Twin Transfusion Syndrome the optimal duration of therapy of methotrexate has not yet been determined, but preliminary data suggest that the initial effect for at least 2 years in case of supporting units, after stopping methotrexate treatment symptoms may return in 3-6 weeks.